Other OTC - Other OTC Delayed Price. Currency in USD
-0.03 (-9.09%)
At close: 1:45PM EST
Stock chart is not supported by your current browser
Previous Close0.28
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Avg. VolumeN/A
Market CapN/A
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire5 months ago

    Wize Announces Closing of Merger

    Wize Pharma, Inc. (formerly known as OphthaliX, Inc.) (Wize) (OTC Pink: WIZP) today announced the closing of its previously announced merger with Wize Pharma Ltd., a clinical-stage biopharmaceutical company (Wize Israel), focused on the treatment of ophthalmic disorders. "Wize's transition to the U.S. public market marks a significant milestone for us, and serves as testament to the determination of our team as well as the support of our investors to date," stated Ron Mayron, Chairman of the Board of Directors of Wize.

  • We're sorry this is all we were able to find about this topic.